Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs

Cancer Science

Volumn 96, Issue 9, 2005, Pages 620-626

  Yanagihara, Miyako ^a   Katano, Masayoshi ^a   Takahashi Sasaki, Noriko ^a   Kimata, Kiyonori ^a   Taira, Kazunari ^b   Andoh, Toshiwo ^a  

^a SOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DNA TOPOISOMERASE; ISOPROTEIN; PACLITAXEL; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN SERINE THREONINE KINASE; RIBOZYME; STAUROSPORINE; TENIPOSIDE; TUBULIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL STRAIN HEK293; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; DRUG TARGETING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; HELA CELLS; HUMANS; KIDNEY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 27144435807     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00088.x     Document Type: Article

References (40)

1. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine threonine kinase containing a SH2-like region. Science 1991; 254: 274-7.
2. Bellacosa A, Franke TF, Gonzales-Portal ME et al. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene 1991; 8: 745-54.
3. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci 2004; 29: 233-41.
4. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Nat Acad Sci USA 2001; 98: 10 983-5.
5. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev Cancer 2002; 2: 489-502.
6. Datta SR, Burnet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2906-27.
7. Cardone MH, Roy N, Steenieke HR et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318-21.
8. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41.
9. Del Peso L, Gonzales-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687-9.
10. Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-68.
11. Kops GJ, de Ruiter ND, de Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398: 630-4.
12. Stambolic V, Suzuki A, Pompa J et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95: 29-39.
13. Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancers. Science 1997; 275: 1943-7.
14. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MSAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1998; 95: 15 587-91.
15. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 1987; 84: 5034-7.
16. Cheng JQ, Godwin AK, Bellacosa A et al. Akt2, a putative oncogene encoding a member of subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 1992; 89: 9267-71.
17. Wang Q, Somwar R, Bilan PJ et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999; 19: 4008-18.
18. Miyake S, Makimura M, Kanegae Y et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-4.
19. Sano M, Taira K. Ribozyme expression systems. Methods Mol Biol 2004; 252: 195-207.
20. Chen C, Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 1988; 6: 632-8.
21. Wang HG, Takayama S, Rapp UR, Reed JC. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 1996; 93: 7063-8.
22. Alley MC, Scudiero DA, Monks A et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
23. Sambrook J, Russel DW. Protocol 1: Purification of RNA from cells and tissues by acid phenol-guanidinium thiocyanate-chloroform extraction. In: Sambrook, J, Russel, DW, eds. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press 2001; 7.4-7.8.
24. Sambrook J, Russel DW. Protocol 11: Ribonuclease protection: Mapping RNA with ribonuclease and radiolabeled RNA probes. In: Sambrook J, Russel DW, eds. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press 2001; 7.63-7.74.
25. Kanegae Y, Lee G, Sato Y et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995; 23: 3816-21.
26. Kanegae Y, Takamori K, Sato Y, Lee G, Nakai M, Saito I. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 1996; 181: 207-12.
27. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-9.
28. Yao R, Cooper GM. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-6.
29. Dudek H, Datta SR, Franke TF et al. Regulation of neuronal survival by the serine/threonine protein kinase Akt. Science 1997; 275: 661-5.
30. Zinda MJ, Johnson MA, Paul JD et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res 2001; 7: 2475-9.
31. Jiang K, Coppola D, Crespo NC et al. The phosphoinositide 3-OH kinase/Akt2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis. Mol Cell Biol 2000; 20: 139-48.
32. Cho H, Mu J, Kim JK et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 2001; 292: 1728-31.
33. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001; 276: 38 349-52.
34. Chen WS, Xu PZ, Gottlob K et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001; 15: 2203-8.
35. Yang ZZ, Tschopp O, Baudry A, Dummler BB, Hynx D, Hemmings BA. Physiological functions of protein kinase B/Akt. Biochem Soc Trans 2004; 32: 350-4.
36. Krystal GW, Sulanke G, Litz J. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther 2002; 1: 913-22.
37. Liu X, Shi Y, Han EKH et al. Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells. Neoplasia 2001; 3: 278-86.
38. Czauderna F, Fechtner M, Ayguen H et al. Functional studies of the PI (3)-kinase signaling pathway employing synthetic and expressed siRNA. Nucl Acids Res 2003; 31: 670-82.
39. DeFeo-Jones D, Barnett SF, Fu S et al. Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members. Mol Cancer Ther 2005; 4: 271-9.
40. Wendel HG, de Stanchina E, Fridman JS et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428: 332-7.